Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 34.63 M37.28 M38.83 M40.78 M 151.51 M Research & development 10.02 M10.3 M11.55 M12.7 M 44.57 M Operating income -4.34 M-2.51 M3.28 M-4.78 M -8.36 M Non-Operating Income, Total -967 K-665 K1.88 M1.81 M 2.06 M Interest expense, net of interest capitalized 1.09 M353 K13 K18 K 1.48 M Non-Operating Income, excl. Interest Expenses -2.06 M-1.02 M1.86 M1.79 M 579 K Unusual income/expense ———— — Pretax income -5.31 M-3.18 M5.16 M-2.97 M -6.3 M Equity in earnings ———— — Taxes 0000 0 Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -5.31 M-3.18 M5.16 M-2.97 M -6.3 M Discontinued operations ———— — Net income -5.31 M-3.18 M5.16 M-2.97 M -6.3 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -5.31 M-3.18 M5.16 M-2.97 M -6.3 M Basic earnings per share (Basic EPS) -0.24-0.061.1-0.05 0.75 Diluted earnings per share (Diluted EPS) -0.24-0.061.1-0.05 0.75 Average basic shares outstanding 21.97 M57.66 M36.64 M58.92 M — Diluted shares outstanding 21.97 M57.66 M36.64 M58.92 M — EBITDA -2.99 M-1.15 M4.73 M-3.27 M -2.69 M EBIT -4.34 M-2.51 M3.28 M-4.78 M -8.36 M Cost of revenue 21.07 M22.96 M22.18 M29.36 M 95.56 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 1.35 M1.36 M1.45 M1.51 M 5.67 M